ARCHIVES

Agency Expands Gleevec Label To Include Rare GIST Subset

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007

Professional Fundraiser Poses Eight Questions For SU2C 3.

September 19, 2008

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

NCI CTEP-Approved Trials For the Month of November

November 28, 2014

Flint Chop Shows That Successful Community Program Can Be Developed And Operated Without NCI Funding

January 21, 1983